MR imaging in children with transverse myelitis and acquired demyelinating syndromes.

[1]  D. Arnold,et al.  Comparison of Spinal Cord Magnetic Resonance Imaging Features Among Children With Acquired Demyelinating Syndromes , 2021, JAMA Network Open.

[2]  Y. Kong,et al.  Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis. , 2020, Brain : a journal of neurology.

[3]  S. Vukusic,et al.  Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study , 2020, Multiple sclerosis.

[4]  K. Tyler,et al.  Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody , 2019, JAMA neurology.

[5]  E. Tantsis,et al.  Magnetic resonance imaging in enterovirus‐71, myelin oligodendrocyte glycoprotein antibody, aquaporin‐4 antibody, and multiple sclerosis‐associated myelitis in children , 2018, Developmental medicine and child neurology.

[6]  K. Rostásy,et al.  MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein , 2018, Journal of Neurology.

[7]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[8]  K. Rostásy,et al.  Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome , 2017, Neurology.

[9]  O. Ciccarelli,et al.  Diagnostic algorithm for relapsing acquired demyelinating syndromes in children , 2017, Neurology.

[10]  Jacqueline A Palace,et al.  Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis , 2017, Brain : a journal of neurology.

[11]  F. Paul,et al.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome , 2016, Journal of Neuroinflammation.

[12]  K. Deiva,et al.  Pediatric transverse myelitis , 2016, Neurology.

[13]  B. Ertl-Wagner,et al.  Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[14]  K. Rostásy,et al.  Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  L. Becerra,et al.  Pain and spinal cord imaging measures in children with demyelinating disease , 2015, NeuroImage: Clinical.

[16]  A. Traboulsee,et al.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2015, Neurology.

[17]  Jacqueline A Palace,et al.  Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[18]  K. Fujihara,et al.  Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders , 2014, Neurology.

[19]  T. Lotze,et al.  Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis , 2012, Journal of child neurology.

[20]  M. Bang,et al.  Spinal Cord Atrophy and Early Motor Recovery following Transverse Myelitis in Pediatric Patients , 2012, Annals of rehabilitation medicine.

[21]  A. Lutterotti,et al.  Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders , 2011, Journal of Neuroinflammation.

[22]  C. Fitz,et al.  Idiopathic acute transverse myelitis in children: an analysis and discussion of MRI findings , 2011, Multiple sclerosis.

[23]  L. Morrison,et al.  Proposed diagnostic criteria and nosology of acute transverse myelitis , 2003 .